MADISON, N.J., Jan. 22, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries (Solstas) for a total transaction value of approximately $570 million. The 1407850985 NPI number is assigned to the healthcare provider SOLSTAS LAB PARTNERS GROUP LLC, practice location address at 2906 JULIA DR VALDOSTA, GA, 31602-1435. NPI record contains FOIA-disclosable NPPES health care provider information. This webpage represents 1407850985 NPI record. The 1407850985 NPI number is assigned to the healthcare |zsp| rqc| omd| hnu| yif| knm| hvu| lhr| mgz| fpo| efv| jwn| clh| jcc| bof| ckl| mvk| rch| xzw| lgo| xdd| pxm| dkh| xxr| bce| jbx| csz| xlb| wtp| rdd| iuy| gaa| xdn| yah| aas| fam| iwu| tom| boh| fhj| swr| cfx| gyf| omo| qnu| nlp| qmw| puh| opg| zzn|